Quantitative and qualitative analysis of in vivo Doppler signal enhancement of FS-069

Investigative Radiology

Volumn 37, Issue 1, 2002, Pages 1-6

  Schaffler, G J ^a,c   Kugler, C H ^a   Schreyer, G ^a   Graber, G ^b   Uggowitzer, M M ^a  

^a UNIVERSITY HOSPITAL GRAZ   (Austria)

^b GRAZ UNIVERSITY OF TECHNOLOGY   (Austria)

^c UNIVERSITY OF GRAZ   (Austria)

Author keywords

Doppler signal enhancement; Femoral vein; Optison; Time intensity curve; Ultrasound

Indexed keywords

CONTRAST MEDIUM; FS 069; MICROSPHERE;

ADULT; ARTICLE; BOLUS INJECTION; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DOPPLER ECHOGRAPHY; FEMORAL VEIN; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; IMAGE ENHANCEMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SCORING SYSTEM; SIDE EFFECT; SIGNAL DETECTION; VELOCITY;

EID: 0036135858     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-200201000-00002     Document Type: Article

References (22)

1. Echocardiography of the aortic root
2. Ultrasound contrast agents
3. Doppler enhancement with SHU 508A in multiple vascular regions
4. Prolongation and optimization of Doppler enhancement with a microbubble US contrast agent by using continuous infusions: Preliminary results
5. Albunex and beyond
6. Intravenous perfluoropropane-exposed sonicated dextrose albumin produces myocardial ultrasound contrast that correlates with coronary blood flow
7. Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging
8. Infusion versus bolus of an ultrasound contrast agent in vivo dose -response measurements of BRI
9. Physical and biochemical stability of Optison, an injectable ultrasound contrast agent
10. Intravenous Optison (FS069) enhances pulmonary vein flow velocity signals: A multicenter study
11. Quantitative echo contrast concentration measurement by Doppler sonography
12. Enhancement of mitral regurgitation and normal left atrial color Doppler flow signals with peripheral venous injection of a saccharide-based contrast agent
13. Contrast-enhanced transcranial Doppler US with a new transpulmonary echo contrast agent based on saccharide microparticles
14. Improved investigation of portalhepatic veins by echo-enhanced Doppler sonography
15. Galactose-based intravenous sonographic contrast agents: Experimental studies
16. Ultrasound contrast agents in liver imaging
17. Ultrasound contrast enhancement of tumors
18. Infusion versus bolus of an ultrasound contrast agent: In vivo dose-response measurements of BRI
19. Developments in echo-enhancing agents
20. Hemodynamic characteristics, myocardial kinetics and microvascular theology of FS069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection
21. Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent: Result of a phase III multicenter trial
22. Clinical safety of SonoVue, a new contrast agent for ultrasound imaging, in healthy volunteers and in patients with chronic obstructive pulmonary disease